Moreover, the spectrum of genetic variants identified in our patients—including TNFRSF13B, DOCK8, RAG1, and LRBA—closely resembles the mutational landscape reported in prior studies of CVID and other antibody deficiencies [21, 22, 24, 26–28]. This evidence concerns the gene LRBA and agammaglobulinemia.